While AMGEN Inc has overperformed by 1.00%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMGN rose by 6.10%, with highs and lows ranging from $346.85 to $257.80, whereas the simple moving average fell by -7.48% in the last 200 days.
On November 15, 2024, Wolfe Research started tracking AMGEN Inc (NASDAQ: AMGN) recommending Peer Perform. A report published by Citigroup on November 14, 2024, Initiated its previous ‘Neutral’ rating for AMGN. Bernstein also rated AMGN shares as ‘Outperform’, setting a target price of $380 on the company’s shares in an initiating report dated October 17, 2024. Truist October 14, 2024d the rating to Hold on October 14, 2024, and set its price target from $320 to $333. Cantor Fitzgerald initiated its ‘Overweight’ rating for AMGN, as published in its report on September 27, 2024. Wells Fargo’s report from August 07, 2024 suggests a price prediction of $335 for AMGN shares, giving the stock a ‘Equal Weight’ rating. William Blair also rated the stock as ‘Outperform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of AMGEN Inc (AMGN)
Investors in AMGEN Inc will get a return regardless of how the company performs over the next quarter since the company’s dividend stands at $9.00 per share. Further, the quarter-over-quarter increase in sales is 23.11%, showing a positive trend in the upcoming months.
One of the most important indicators of AMGEN Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 55.72% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.96, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and AMGN is recording 2.60M average volume. On a monthly basis, the volatility of the stock is set at 2.87%, whereas on a weekly basis, it is put at 3.24%, with a loss of -2.42% over the past seven days. Furthermore, long-term investors anticipate a median target price of $329.57, showing growth from the present price of $282.87, which can serve as yet another indication of whether AMGN is worth investing in or should be passed over.
How Do You Analyze AMGEN Inc Shares?
The Drug Manufacturers – General market is dominated by AMGEN Inc (AMGN) based in the USA. When comparing AMGEN Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 36.22, there is a growth in quarterly earnings of 62.38%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.26%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 77.99% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
AMGN shares are owned by institutional investors to the tune of 77.99% at present.